ALLO - Allogene Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts19191918
Avg. Estimate-0.59-0.56-2.36-2.33
Low estimate-0.68-0.7-2.78-3.06
High estimate-0.52-0.47-2.17-1.69
Year ago EPS-0.52-0.58-2.32-2.36
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts18181816
Avg. Estimate20k20k70k20k
Low estimateN/AN/AN/AN/A
High estimate100k100k230k200k
Year ago sales86k10k243k70k
Sales growth (year/est)-76.70%100.00%-71.20%-71.40%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.61-0.64-0.7-0.62
Actual EPS-0.52-0.58-0.66-0.68
Difference0.090.060.04-0.06
Surprise %14.80%9.40%5.70%-9.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.59-0.56-2.36-2.33
7 days ago-0.59-0.56-2.36-2.33
30 days ago-0.59-0.56-2.36-2.34
60 days ago-0.61-0.61-2.44-2.52
90 days ago-0.61-0.62-2.43-2.49
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/AN/AN/A
Growth estimatesALLOIndustrySector(s)S&P 500
Current qtr.-13.50%N/AN/AN/A
Next qtr.3.40%N/AN/AN/A
Current year-1.70%N/AN/AN/A
Next year1.30%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A